Heparin Sodium in 5% Dextrose Injection, 25000unit/500ml 5000 Unit (Heparin Sodium SOLUTION) 5000 UNIT

Heparin Sodium in 5% Dextrose Injection is an anticoagulant solution used to prevent blood clots. This intravenous solution combines heparin sodium with dextrose for medical use.

Strength

5000 UNIT

Pack Size

500ML

Manufacturer / TM Owner

B. BRAUN MEDICAL INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Heparin Sodium in 5% Dextrose Injection is primarily used to prevent and treat blood clots in the blood vessels. It is often administered intravenously to maintain blood flow and reduce the risk of clotting during medical procedures. This solution is commonly used in hospitals and clinical settings for patients requiring anticoagulation therapy.

Side Effects

Heparin Sodium in 5% Dextrose Injection works by inhibiting the clotting process in the blood. Common effects may include prolonged bleeding times and reduced clotting ability. Patients may experience bruising or bleeding at injection sites.

Precautions & Warnings

Heparin Sodium should be handled with care to avoid contamination. It is essential to follow medical guidelines for administration and storage. Patients with a history of bleeding disorders or allergies to heparin should consult a healthcare provider before use.

Avoid Interactions

Heparin Sodium may interact with other anticoagulants, antiplatelet drugs, and certain antibiotics. It is important to inform healthcare providers about all medications being taken to avoid adverse interactions. Alcohol consumption should be moderated as it can increase the risk of bleeding.

Frequently Asked Questions

Heparin Sodium is used to prevent and treat blood clots in the blood vessels, often administered intravenously.

This solution is typically administered intravenously by healthcare professionals in clinical settings.

Common effects include prolonged bleeding times and reduced clotting ability, which may result in bruising or bleeding at injection sites.

Patients with a history of bleeding disorders or allergies to heparin should consult a healthcare provider before use.

Yes, it may interact with other anticoagulants, antiplatelet drugs, and certain antibiotics. Always inform healthcare providers about all medications being taken.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.